Piper Jaffray Starts GlaxoSmithKline (GSK) at Overweight
Tweet
Share
E-mail
Get Alerts GSK Hot Sheet
Price: $41.24 --0%
Rating Summary:
8 Buy, 13 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 14
Rating Summary:
8 Buy, 13 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 14
Join SI Premium – FREE
Piper Jaffray initiated coverage on GlaxoSmithKline (NYSE: GSK) with an Overweight rating.
For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.
Shares of GlaxoSmithKline closed at $43.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
- CICC Starts Southern Copper (SCCO) at Outperform
- Piper Sandler Starts Kura Sushi USA Inc. (KRUS) at Neutral, 'Risk Reward as relatively balanced'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
